Medical Oncology

Prof. Dr. Yeşim Eralp

Doctor and researcher Acıbadem Maslak Hastanesi İstanbul
Breast NeoplasmsOvarian NeoplasmsLung NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Non-Small-Cell LungCarcinomaNeoplasms, Glandular and EpithelialBrain NeoplasmsLymphoma, Non-HodgkinAdenocarcinomaBone NeoplasmsCarcinoma, LobularCarcinoma, Ovarian EpithelialThymomaThymus NeoplasmsNeoplasmsSarcomaCarcinoma, Squamous CellCystadenocarcinoma, PapillaryAdenocarcinoma, Clear CellCarcinoma, EndometrioidCystadenocarcinoma, SerousUterine Cervical NeoplasmsEsophageal NeoplasmsBalanitis
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

The CV details on this page were translated automatically from the language of the source. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 25 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Ovarian Neoplasms 16 publications
  • Lung Neoplasms 13 publications
  • Carcinoma, Ductal, Breast 6 publications
  • Carcinoma, Non-Small-Cell Lung 6 publications
  • Carcinoma 4 publications
  • Neoplasms, Glandular and Epithelial 3 publications
  • Brain Neoplasms 3 publications
  • Lymphoma, Non-Hodgkin 3 publications
  • Adenocarcinoma 3 publications
  • Bone Neoplasms 2 publications
  • Carcinoma, Lobular 2 publications
  • Carcinoma, Ovarian Epithelial 2 publications
  • Thymoma 2 publications
  • Thymus Neoplasms 2 publications
  • Neoplasms 2 publications
  • Sarcoma 2 publications
  • Carcinoma, Squamous Cell 2 publications
  • Cystadenocarcinoma, Papillary 2 publications
  • Adenocarcinoma, Clear Cell 2 publications
  • Carcinoma, Endometrioid 2 publications
  • Cystadenocarcinoma, Serous 2 publications
  • Uterine Cervical Neoplasms 2 publications
  • Esophageal Neoplasms 2 publications
  • Balanitis 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Oral cancer
  • Head and neck cancers
  • Brain tumours
  • Kidney cancer
  • Adrenal cancer
  • Lung and pleural cancers (mesothelioma) and other thoracic cancers
  • Cancer of the tongue and tongue base
  • Anal cancer
  • Nasal cavity tumours
  • Malignant melanoma and other skin tumours
  • Lung cancer
  • Tongue cancer

CV

Education and experience

From source

Experience

  • 2019Acıbadem Healthcare Groupacibadem.com.tr
  • 2018 - 2019İstanbul Florence Nightingale Hospital / Medical Oncologistacibadem.com.tr
  • 2010 - 2018İstanbul University Institute of Oncology / Faculty Memberacibadem.com.tr
  • 2008 - 2010İstanbul University Institute of Oncology / Member of the Board of Directors – Deputy Director for Research and Educationacibadem.com.tr
  • 2004 - 2009İstanbul University Institute of Oncology / İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Associate Professor of Medical Oncologyacibadem.com.tr
  • 2001 - 2002Department of Bioimmunotherapy, Visiting Medical Oncologist: Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas / Postdoctoral Fellowacibadem.com.tr
  • 2001 - 2004İstanbul University Institute of Oncology / Medical Oncologistacibadem.com.tr

Education

  • 2001İstanbul University İstanbul Faculty of Medicine, Medical Oncology (subspecialty)acibadem.com.tr
  • 1997İstanbul University Cerrahpaşa Faculty of Medicine, Internal Medicine (specialty training)acibadem.com.tr
  • 1991İstanbul University İstanbul Faculty of Medicine (medical degree)acibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 25 publications · Model version —From source
  • Publications193 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-9603-4755ORCIDFrom source
  • Last synchronised4 November 2026 20:47https://www.acibadem.com.tr/doktor/yesim-eralp/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

193 publications

  1. Abstract PS4-11-08: Clinical characteristics and prognosis in interval detected breast cancer patients: a single institution cohort analysis

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-11-08 Source: OpenAlex

  2. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology

    European Journal of Breast Health, 2026

    DOI 10.4274/ejbh.galenos.2026.2025-10-1 PMID 41873792 Open-access full textSource: OpenAlex

  3. Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61177-3 PMID 42414499 Open-access full textSource: OpenAlex

  4. Investigating the feasibility of cascade genetic testing for BRCA1/2 in Türkiye: physicians' practices, barriers, and solutions

    European Journal of Cancer Care, 2026

    DOI 10.48130/ejcc-0026-0010 Source: OpenAlex

  5. DNA Methylation Signatures Distinguish Breast Cancer Histological Subtypes and Predict Hormone Receptor Status: A TCGA-Based Integrative Analysis

    Experimed, 2026

    DOI 10.26650/experimed.1930098 Open-access full textSource: ORCID

  6. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic Treatment

    European Journal of Breast Health, 2025

    DOI 10.4274/ejbh.galenos.2025.2025-10-2 PMID 41447641 Open-access full textSource: OpenAlex

  7. 42P Concordance of CanAssist breast with Oncotype Dx and MammaPrint in patients with early stage hormone receptor positive breast cancer

    ESMO Open, 2025

    DOI 10.1016/j.esmoop.2025.104596 Open-access full textSource: OpenAlex

  8. Metastatic Mixed-Type Liposarcoma of the Popliteal Fossa: Multimodal Treatment

    Springer eBooks, 2025

    DOI 10.1007/978-3-031-77061-6_31 Source: ORCID

  9. First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive hormone receptor (HR)+/HER2− advanced breast cancer (ABC): A subgroup analysis of patients (pts) with or without liver metastases (mets) from RIGHT Choice.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.1069 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. Abstract PS2-06: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive HR+/HER2- advanced breast cancer (ABC): a subgroup analysis of RIGHT Choice by intrinsic subtype & gene & signature expression

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-ps2-06 1 citation (OpenAlex) Source: OpenAlex

View all 193 publications